Literature DB >> 19898429

Pfizer settles largest ever fraud suit for off-label promotion.

Mark Ratner.   

Abstract

Mesh:

Year:  2009        PMID: 19898429     DOI: 10.1038/nbt1109-961

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN: 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  1 in total

1.  Off-label or off-limits?

Authors:  Mark Ratner; Trisha Gura
Journal:  Nat Biotechnol       Date:  2008-08       Impact factor: 54.908

  1 in total
  4 in total

1.  Crossing the line.

Authors:  Mark Ratner
Journal:  Nat Biotechnol       Date:  2010-12       Impact factor: 54.908

2.  Off-licence prescribing and regulation in psychiatry: current challenges require a new model of governance.

Authors:  Philip Sugarman; Amy Mitchell; Catherine Frogley; Geoffrey L Dickens; Marco Picchioni
Journal:  Ther Adv Psychopharmacol       Date:  2013-08

3.  Ten common questions (and their answers) about off-label drug use.

Authors:  Christopher M Wittich; Christopher M Burkle; William L Lanier
Journal:  Mayo Clin Proc       Date:  2012-08-06       Impact factor: 7.616

4.  Unbalanced reporting of benefits and harms in abstracts on rofecoxib.

Authors:  Anders W Jørgensen; Karsten Juhl Jørgensen; Peter C Gøtzsche
Journal:  Eur J Clin Pharmacol       Date:  2010-02-17       Impact factor: 2.953

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.